anti- ABHD5 antibody

Este producto es parte de ABHD - Abhydrolase Domain Containing
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti- ABHD5 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00050
tested applications
ELISA, WB, IF, IHC

Description

Lysophosphatidic acid acyltransferase which functions in phosphatidic acid biosynthesis(PubMed:18606822). May regulate the cellular storage of triacylglycerol through activation of the phospholipase PNPLA2(PubMed:16679289). Involved in keratinocyte differentiation(PubMed:18832586). Regulates lipid droplet fusion(By similarity).

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
Primary Antibodies
Immunogen Target
abhydrolase domain containing 5
Host
Rabbit
Reactivity
human,mouse
Recommended Dilution
WB: 1:200-1:2000; IHC: 1:20-1:200; IF: 1:10-1:100
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
39 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IF, IHC
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q8WTS1
Gene ID
51099
Alias
CGI58,IECN2,NCIE2
Background
Antibody anti-ABHD5
Status
RUO
Note
This product is for research use only.

Descripción

ABHD5, also known as CGI-58, is a critical coactivator of adipose triglyceride lipase (ATGL), a key enzyme in lipolysis. It promotes the hydrolysis of triglycerides into glycerol and free fatty acids, thereby regulating lipid storage and energy metabolism. ABHD5 is highly expressed in adipose tissue, liver, and muscles, where it plays an essential role in lipid mobilization and energy balance. Mutations in the ABHD5 gene are associated with Chanarin-Dorfman syndrome, a rare lipid storage disorder characterized by excessive lipid accumulation in various tissues. Beyond lipolysis, ABHD5 influences lipid signaling pathways and cellular lipid composition, affecting processes such as inflammation and metabolic homeostasis. Dysregulation of ABHD5 activity can contribute to obesity, insulin resistance, and other metabolic syndromes, highlighting its critical role in energy regulation and lipid metabolism.

Related Products

FNab00050

anti- ABHD5 antibody

Lysophosphatidic acid acyltransferase which functions in phosphatidic acid biosynthesis(PubMed:18606822). May regulate the cellular storage of triacylglycerol through activation of the phospholipase PNPLA2(PubMed:16679289). Involved in keratinocyte differentiation(PubMed:18832586). Regulates lipid droplet fusion(By similarity).

Ver Producto
P2144

Recombinant Human ABHD5

Ver Producto
abx005216

1-Acylglycerol-3-Phosphate O-Acyltransferase ABHD5 (ABHD5) Antibody

ABHD5 Antibody is a Rabbit Polyclonal antibody against ABHD5. The protein encoded by this gene belongs to a large family of proteins defined by an alpha/beta hydrolase fold, and contains three sequence motifs that correspond to a catalytic triad found in the esterase/lipase/thioesterase subfamily. It differs from other members of this subfamily in that its putative catalytic triad contains an asparagine instead of the serine residue. Mutations in this gene have been associated with Chanarin-Dorfman syndrome, a triglyceride storage disease with impaired long-chain fatty acid oxidation.

Ver Producto